交易 Tectonic Therapeutic Inc - TECX 差价合约
Tectonic Therapeutic Inc (NASDAQ: TECT) is a biotechnology company developing novel GPCR-targeted therapies for rare and chronic diseases. Using structure-based drug design and proprietary platform technology, it aims to unlock previously undruggable receptors. Tectonic’s shares move with clinical milestones, licensing partnerships, and progress advancing its pipeline of precision therapeutics.最新股票文章

SpaceX上市首日收涨19%——IPO后如何交易SpaceX SPCX差价合约
SpaceX(SPCX)于2026年6月12日在纳斯达克首次上市,开盘报150美元,收盘报160.95美元,较135美元的IPO发行价上涨19.2%。
08:41, 16 六月 2026


